GlassScriptPhysician profile
Jane M Bridges
NPI 1528148434
$27,537.36
in general payments reported to CMS, 2019-2025
11 companies · $361 in 2025
The $361 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $804 · 2021: $4,360 · 2022: $183 · 2023: $2,277 · 2024: $1,615 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,740 · Food and Beverage: $1,346 · Travel and Lodging: $1,102 · Education: $64.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,740.00 |
| Food and Beverage | $1,346.18 |
| Travel and Lodging | $1,102.12 |
| Education | $64.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $21,666.14 | 2019-2022 | |
| Novo Nordisk INC | $1,830.31 | 2019-2025 | |
| Medtronic, INC. | $1,714.72 | 2021-2025 | Minimed 780g |
| Abbott Laboratories | $1,300.00 | 2021 | |
| Dexcom, INC. | $406.92 | 2022-2024 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Tandem Diabetes Care, INC. | $264.73 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic Minimed, INC. | $161.21 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $120.65 | 2025 | |
| Companion Medical, INC. | $48.50 | 2019 | |
| Lilly USA, LLC | $13.44 | 2022 | |
| Echosens North America, INC. | $10.74 | 2025 | Fibroscan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Bridges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.